• In 2008, Stéphane Lavallée, PhD, an experienced entrepreneur in Computer Assisted Surgery, and Professor Eric Stindel, MD, PhD, who is considered one of the top international clinical experts in computer assisted orthopedic surgery, analyzed the markets and available technologies in early arthritis treatment, and realized there was a huge opportunity in developing and marketing a solution entirely focused on computer-assisted tibial osteotomies. They decided to partner and found a company reflecting their vision. At that time, Guillaume Dardenne was finishing his PhD thesis at Telecom Bretagne and was considered the best PhD engineer of his generation in this field. Immediately, Guillaume Dardenne embraced the project with enthusiasm. The team was then joined by two highly experienced Professors, one on the clinical side, Pr Christian Lefevre, MD, Brest Hospital, and the other on the scientific side, Pr. Christian Roux, PhD., Telecom Institute, both bringing a clinical and scientific network and a solid experience in surgical techniques, medical imaging and innovations.
  • In 2009, the OSTESYS project took off and benefitted, from the outset, from the support of Brest University (UBO), Brest Hospital (CHU) and the Telecom Institute, with the objective of fine-tuning the market analysis, the IP analysis and the technology concept. The company OSTESYS was incorporated on March 25th 2009, in the outskirts of Brest.
  • In 2010, OSTESYS received a 125,000€ grant from the French Ministry of Research and Education (“Oseo Création Développement”).

  • In 2011, Pierre-Yves Huet joined the R&D team as mechanical project manager was in charge of the design of the instrument and implants.
  • At the beginning of 2012, three famous US orthopedic surgeons and one UK orthopedic surgeon have decided to join the OSTESYS team: Dr James Stiehl, MD, Dr Matthew Matava, MD, Dr Robert Brophy, MD for the USA and Dr Leela Biant, MD.

  • In 2013, Pierre-Yves has been nominated CEO of OSTESYS because of exceptional efficiency recognized by the initial founders.
  • The current technology has already been validated during year 2013 and 2014, on anatomical specimens in cadaver labs of Saint Louis (USA) and Brest (France). This technology is extremely well perceived by our experts.